Owners, management and financials
CVR: 40518916
Previous names: Udveje ApS
DKK 4,937,535
Gross profit
Net result: DKK 64,996
UDVEJE Holding ApS (100%)
CVR · view owners
John Kastrup
Board: Rolf Nolsøe Bau (chair) and 3 members
CVR · view management
Active
Founded 14 May 2019
CVR · view overview
9 employees
Annual report 2025 · average
Name registered: Udveje Behandling Aps
CVR · 29/01/2021
View the full event history
Udveje Behandling Aps is a Danish company of the type Anpartsselskab based in Store Merløse, founded in 2019. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Udveje ApS. The management consists of John Kastrup. The board consists of Rolf Nolsøe Bau (chair), Chit Calopez Lodberg, Claus Christiansen and Kirsten Benediktson. The company is owned by UDVEJE Holding ApS. According to the 2025 annual report, the company had an average of 9 employees. In 2025, the company reported a gross profit of DKK 4,937,535 and a net result of DKK 64,996 compared with DKK 541,297 the year before. Equity in the 2025 report amounted to DKK 675,868.
Source: annual report 2025, Danish Business Authority
The financial health of Udveje Behandling Aps appears stable, with a notable upward trend in gross profit and profit over the past few years. Gross profit increased from 1,066,649 DKK in 2021 to 4,937,535 DKK in 2025, while profit rose from 222,294 DKK to 64,996 DKK during the same period, indicating strong operational efficiency. However, equity has shown a decline from 960,872 DKK in 2024 to 675,868 DKK in 2025, raising concerns about financial sustainability. As a relatively young player in the traditional and alternative treatment industry, the company has demonstrated significant growth potential but may need to address its equity position to ensure long-term viability.
AI-generated summary · Generated 16/08/2026
Selskabets formål er at drive virksomhed med terapi og behandling samt kursus og uddannelse samt enhver i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | 4.9 mio. | 65 t. | 2.2 mio. | 676 t. | 9 | |
| 202401/10/2023 – 30/09/2024 | 4.5 mio. | 541 t. | 2.3 mio. | 961 t. | - | |
| 202301/10/2022 – 30/09/2023 | 4.9 mio. | 710 t. | 2.6 mio. | 775 t. | 7 | |
| 202201/10/2021 – 30/09/2022 | 2 mio. | 237 t. | 1.1 mio. | 445 t. | - | |
| 202101/10/2020 – 30/09/2021 | 1.1 mio. | 222 t. | 426 t. | 208 t. | - |
Compared to 475 companies in Traditionelle, komplementære og alternative behandlingsformer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Udveje Behandling Aps is 40518916.
Udveje Behandling Aps is owned by UDVEJE Holding ApS.
The management of Udveje Behandling Aps consists of John Kastrup.
The board of Udveje Behandling Aps consists of Rolf Nolsøe Bau, Chit Calopez Lodberg and Claus Christiansen, with Rolf Nolsøe Bau as chair.
In 2025, Udveje Behandling Aps reported a gross profit of DKK 4,937,535.
Udveje Behandling Aps had an average of 9 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Address changed to Bonderupvej 150, 4370 Store Merløse (June 8, 2026).
Contact info changed: new phone: 50559011, new email: [email protected], new website: www.udveje.dk (June 8, 2026).
Udveje Behandling Aps has published its annual report for 2025. Gross profit came to DKK 4,937,535, and the net result was DKK 64,996.
As of March 26, 2026, Rolf Nolsøe Bau has joined the board of directors of Udveje Behandling Aps.
As of March 26, 2026, Michael Mølgaard has left the board of directors of Udveje Behandling Aps.
As of March 25, 2026, Rolf Nolsøe Bau has left the board of directors of Udveje Behandling Aps.
Udveje Behandling Aps has published its annual report for 2024. Gross profit came to DKK 4,473,923, and the net result was DKK 541,297.
Udveje Behandling Aps has published its annual report for 2023. Gross profit came to DKK 4,873,418, and the net result was DKK 710,064.
As of May 24, 2023, Kirsten Benediktson has joined the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Michael Mølgaard has joined the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Chit Calopez Lodberg has joined the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Tanja Schlein Andersen has left the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Kenn Vagn Thomsen has left the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Ole Vedel Rasmussen has left the board of directors of Udveje Behandling Aps.
Udveje Behandling Aps has published its annual report for 2022. Gross profit came to DKK 1,964,105, and the net result was DKK 236,798.
Udveje Behandling Aps has published its annual report for 2021. Gross profit came to DKK 1,066,649, and the net result was DKK 222,294.
As of January 29, 2022, Rolf Nolsøe Bau has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Claus Christiansen has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Tanja Schlein Andersen has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Kenn Vagn Thomsen has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Ole Vedel Rasmussen has joined the board of directors of Udveje Behandling Aps.
Udveje Behandling Aps has published its interim report for the period May 14, 2019 – September 30, 2020.
On January 29, 2021, the company changed its name from Udveje ApS to Udveje Behandling Aps.
As of March 1, 2020, Michael Steffen Pedersen has stepped down as director of Udveje Behandling Aps.
As of May 14, 2019, John Kastrup is registered as director of Udveje Behandling Aps.
As of May 14, 2019, Michael Steffen Pedersen is registered as director of Udveje Behandling Aps.
As of May 14, 2019, UDVEJE Holding ApS is registered as an owner of Udveje Behandling Aps with an ownership share of 100%.
Udveje Behandling Aps was founded on May 14, 2019.
Companies in the same industry and area
CVR 30961137
CVR 31120527
CVR 41082283
CVR 44036991
CVR 41435070
